Skip to main content

COVID-19

Below is an overview of various sections of The Swedish COVID-19 & Pandemic Preparedness Portal where information about research data and resources relevant to COVID-19 can be found. For a short background on this topic below, see the description below.

Data highlights (33)

Direct RT-PCR used to monitor Omicron BA.1/BA.2 variant transition in Sweden (Update) COVID-19 Infectious diseases
Direct RT-PCR used to monitor Omicron BA.1/BA.2 variant transition in Sweden (Update)

2022-08-15

Lentini and collegues used direct RT-PCR to show the transition from Omicron BA.1 to sub-variant BA.2 in Sweden Jan-March 2022. New Preprint from Reinius lab which shares data and code.
Read more

Large scale immunofluorescence to explore the host cell response to SARS-CoV-2 infection COVID-19 Infectious diseases
Large scale immunofluorescence to explore the host cell response to SARS-CoV-2 infection

2022-04-25

Expression of 602 host proteins were evaluated in populations of infected and non-infected cells using immunofluorescence. ≈75,000 images have been published as a resource for further studies.
Read more

Interactions between fragments and SARS-CoV-2 nsp10 provide insight into the viral replications COVID-19 Infectious diseases
Interactions between fragments and SARS-CoV-2 nsp10 provide insight into the viral replications

2022-03-01

Interactions between fragments and SARS-CoV-2 nsp10 have been successfully identified and characterised by Kozielski and colleagues. Data shared on the Protein Data Bank and Zenodo.
Read more


Dashboards (6)


Sample collections (35)

Name Type Size Materials
Dalarna biobank (forskningsprov och nyinsamlade prov):
SARS-CoV-2 PCR positiva Dalarna
Healthcare sample collection 1000 - 10.000 Nasal swab Throat swab
Gävleborg biobank:
Klinisk mikrobiologi
Healthcare sample collection 1000 - 10.000 Nasal swab Serum Throat swab Other
Halland biobank:
Patologen Halland
Healthcare sample collection 100 - 1000 Tissue (stained sections/slides) Tissue (paraffin preserved)

Ongoing research projects (117)

Project title Funder Topics
The COMMUNITY Study - COVID-19 Biomarker and Immunity Study

Host institute: Karolinska Institute / Danderyd Hospital
Principal investigator: Charlotte Thålin

SciLifeLab / Knut and Alice Wallenberg Foundation COVID-19Infectious diseases
Validation and characterisation of novel plasma biomarkers for risk prediction and stratification of COVID-19 patients

Host institute: KTH Royal Institute of Technology
Principal investigator: Jacob Odeberg

SciLifeLab / Knut and Alice Wallenberg Foundation COVID-19Infectious diseases
NEVERMORE COVID – Establishing a drug discovery platform for corona virus disease

Host institute: Uppsala University
Principal investigator: Kristian Sandberg

SciLifeLab / Knut and Alice Wallenberg Foundation COVID-19Infectious diseases

Open funding opportunities (2)

Call title Deadline Funder Topics
The overall objective of the call is to support and accelerate cutting edge Nordic research with high potential for renewal and impact on the welfare among children and young people in the …
December 8, 2022 Swedish Research Council COVID-19General
Your request for free of charge transnational access to ISIDORe services for supporting and advancing your research must be focused on one of; surveillance & epidemic risk management, …
January 1, 2025 ISIDORe Infectious diseasesCOVID-19

Background

Coronavirus disease (COVID-19) is an infectious disease caused by the novel SARS-CoV-2 virus. Since its start in early 2020, the COVID-19 pandemic has challenged societies worldwide. While most people infected experience mild to moderate respiratory illness and recover without treatment, the disease can be severe or fatal. Advanced age and underlying medical conditions, such as cardiovascular disease, diabetes, cancer, or chronic respiratory disease, have all been associated with increased risk of severe outcome. However, anyone independent of age or comorbidities is at risk for COVID-19 severe disease outcome. As of March 2022, more than 200 million confirmed cases and over 4 million deaths have been reported.

The research community worldwide has, in an unprecedented way, focused their research efforts towards investigating the novel SARS-CoV-2 virus and variants, as well as variants of concern (VoCs) have emerged more, and the impact of COVID-19 on human body. These contributions from the research community have been a crucial part of the rapid vaccine development. Vaccines are today the cornerstone of global pandemic management. Whilst vaccines were rolled out in record time and have proven very effective diminishing the risk of severe COVID-19 disease and death, many research questions remain. Although we are now entering a more endemic period, COVID-19 is a serious health threat worldwide. Research and lessons learned are crucial for early detection of outbreaks, ability to rapidly identify potential new SARS CoV-2 variants of concern, development of additional treatment options, and future pandemic preparedness. There is still an uncertainty regarding the duration of vaccine protection and effectiveness of booster doses. In addition, vaccine escape has been shown by several current VoCs which could make vaccines less efficient.